Insulin glargine and lixisenatide Subcutaneous and Timentin Novaplus
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Timentin Novaplus and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: clavulanate / ticarcillin
Brand name: Timentin
Synonyms: Timentin, Timentin Add-Vantage
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Timolide
- Insulin glargine and lixisenatide Subcutaneous-Timolol
- Insulin glargine and lixisenatide Subcutaneous-Timolol (Systemic)
- Insulin glargine and lixisenatide Subcutaneous-Timolol and hydrochlorothiazide
- Insulin glargine and lixisenatide Subcutaneous-Timolol eent
- Insulin glargine and lixisenatide Subcutaneous-Timolol Eye Drops (Bottle)
- Timentin Novaplus-Insulin glargine, recombinant Subcutaneous
- Timentin Novaplus-Insulin glulisine
- Timentin Novaplus-Insulin Glulisine (Cartridges and Pens)
- Timentin Novaplus-Insulin Glulisine (Vials)
- Timentin Novaplus-Insulin glulisine Subcutaneous
- Timentin Novaplus-Insulin human inhaled Inhalation